Lavage cytology diagnosed by immunostaining may be a poor prognostic factor in pathological stage III colorectal cancer
- Akitoshi Nankaku 1,2, Yusuke Yamaoka 1, Akio Shiomi 1, Hiroyasu Kagawa 1, Shoichi Manabe 1, Takuma Oishi 3, Kiyoshi Tone 3, Akifumi Notsu 4, Yusuke Kinugasa 2
- Akitoshi Nankaku 1,2, Yusuke Yamaoka 1, Akio Shiomi 1
- 1Division of Colon and Rectal Surgery Shizuoka Cancer Center Hospital Shizuoka Japan.
- 2Department of Gastrointestinal Surgery, Graduate School of Medicine Tokyo Medical and Dental University Tokyo Japan.
- 3Division of Pathological Diagnosis Shizuoka Cancer Center Hospital Shizuoka Japan.
- 4Division of Clinical Research Center Shizuoka Cancer Center Hospital Shizuoka Japan.
- 0Division of Colon and Rectal Surgery Shizuoka Cancer Center Hospital Shizuoka Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Positive intraoperative lavage cytology (LCY) in stage III colorectal cancer (CRC) patients indicates a poorer prognosis. Immunostaining for LCY is a significant predictor of reduced overall survival and relapse-free survival after surgery.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Colorectal cancer (CRC) remains a significant health concern globally.
- Accurate prognostic markers are crucial for tailoring treatment strategies in pathological stage III CRC.
- Intraoperative lavage cytology (LCY) is increasingly explored as a potential prognostic indicator.
Purpose Of The Study
- To evaluate the prognostic impact of positive lavage cytology (LCY) diagnosed by immunostaining.
- To assess the association between positive LCY and long-term outcomes in patients with pathological stage III CRC undergoing curative resection.
Main Methods
- Retrospective analysis of 708 patients with pathological stage III CRC who underwent radical resection and intraoperative LCY.
- LCY specimens evaluated using Papanicolaou staining and immunostaining (CEA, Ber-EP4).
- Patients classified into positive LCY (LCY+) and negative LCY (LCY-) groups; overall survival (OS) and relapse-free survival (RFS) compared.
Main Results
- Positive LCY was observed in 4.2% of patients (30/708).
- The LCY+ group showed significantly lower 5-year OS (58.7% vs. 91.0%) and RFS (28.8% vs. 76.6%) compared to the LCY- group.
- Multivariate analysis confirmed positive LCY as an independent predictor of poorer OS and RFS.
Conclusions
- Positive intraoperative lavage cytology, particularly when diagnosed by immunostaining, is a significant poor prognostic factor in pathological stage III CRC.
- Immunostaining may detect positive LCY even when Papanicolaou staining is negative, without altering the prognostic significance.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

